Biomarkers in Multiple Sclerosis: Role of Antibodies

The first international workshop on “Biomarkers in Multiple Sclerosis” was organized by B. Bielekova, R. Hohlfeld, R. Martin and U. Utz from April 14–16, 2004, in Washington, DC. The workshop intended to discuss the current status and potential applicability of biological markers for the understandi...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Thomas, Reindl, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2006
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851391/
https://www.ncbi.nlm.nih.gov/pubmed/17124342
http://dx.doi.org/10.1155/2006/602103
_version_ 1782294273464467456
author Berger, Thomas
Reindl, Markus
author_facet Berger, Thomas
Reindl, Markus
author_sort Berger, Thomas
collection PubMed
description The first international workshop on “Biomarkers in Multiple Sclerosis” was organized by B. Bielekova, R. Hohlfeld, R. Martin and U. Utz from April 14–16, 2004, in Washington, DC. The workshop intended to discuss the current status and potential applicability of biological markers for the understanding of the pathogenesis, diagnosis, and therapy of multiple sclerosis. The present review summarizes the presentation on the potential role of antibodies as biomarkers for diagnosis, disease activity, classification and prediction of clinical courses in multiple sclerosis.
format Online
Article
Text
id pubmed-3851391
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-38513912013-12-18 Biomarkers in Multiple Sclerosis: Role of Antibodies Berger, Thomas Reindl, Markus Dis Markers Other The first international workshop on “Biomarkers in Multiple Sclerosis” was organized by B. Bielekova, R. Hohlfeld, R. Martin and U. Utz from April 14–16, 2004, in Washington, DC. The workshop intended to discuss the current status and potential applicability of biological markers for the understanding of the pathogenesis, diagnosis, and therapy of multiple sclerosis. The present review summarizes the presentation on the potential role of antibodies as biomarkers for diagnosis, disease activity, classification and prediction of clinical courses in multiple sclerosis. IOS Press 2006 2006-11-15 /pmc/articles/PMC3851391/ /pubmed/17124342 http://dx.doi.org/10.1155/2006/602103 Text en Copyright © 2006 Hindawi Publishing Corporation.
spellingShingle Other
Berger, Thomas
Reindl, Markus
Biomarkers in Multiple Sclerosis: Role of Antibodies
title Biomarkers in Multiple Sclerosis: Role of Antibodies
title_full Biomarkers in Multiple Sclerosis: Role of Antibodies
title_fullStr Biomarkers in Multiple Sclerosis: Role of Antibodies
title_full_unstemmed Biomarkers in Multiple Sclerosis: Role of Antibodies
title_short Biomarkers in Multiple Sclerosis: Role of Antibodies
title_sort biomarkers in multiple sclerosis: role of antibodies
topic Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851391/
https://www.ncbi.nlm.nih.gov/pubmed/17124342
http://dx.doi.org/10.1155/2006/602103
work_keys_str_mv AT bergerthomas biomarkersinmultiplesclerosisroleofantibodies
AT reindlmarkus biomarkersinmultiplesclerosisroleofantibodies

Ejemplares similares